Literature DB >> 31991148

openPrimeR for multiplex amplification of highly diverse templates.

Christoph Kreer1, Matthias Döring2, Nathalie Lehnen3, Meryem S Ercanoglu1, Lutz Gieselmann1, Domnica Luca1, Kanika Jain1, Philipp Schommers4, Nico Pfeifer5, Florian Klein6.   

Abstract

To study the diversity of immune receptors and pathogens, multiplex PCR has become a central approach in research and diagnostics. However, insufficient primer design against highly diverse templates often prevents amplification and therefore limits the correct understanding of biological processes. Here, we present openPrimeR, an R-based tool for evaluating and designing multiplex PCR primers. openPrimeR provides a functional and intuitive interface and uses either a greedy algorithm or an integer linear program to compute the minimal set of primers that performs full target coverage. As proof of concept, we used openPrimeR to find optimal primer sets for the amplification of highly mutated immunoglobulins. Comprehensive analyses on specifically generated immunoglobulin variable gene segment libraries resulted in the composition of highly effective primer sets (oPR-IGHV, oPR-IGKV and oPR-IGLV) that demonstrated to be particularly suitable for the isolation of novel human antibodies.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Year:  2020        PMID: 31991148     DOI: 10.1016/j.jim.2020.112752

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

1.  Repertoire characterization and validation of gB-specific human IgGs directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMV.

Authors:  Sebastian J Theobald; Christoph Kreer; Sahamoddin Khailaie; Agnes Bonifacius; Britta Eiz-Vesper; Constanca Figueiredo; Michael Mach; Marija Backovic; Matthias Ballmaier; Johannes Koenig; Henning Olbrich; Andreas Schneider; Valery Volk; Simon Danisch; Lutz Gieselmann; Meryem Seda Ercanoglu; Martin Messerle; Constantin von Kaisenberg; Torsten Witte; Frank Klawonn; Michael Meyer-Hermann; Florian Klein; Renata Stripecke
Journal:  PLoS Pathog       Date:  2020-07-15       Impact factor: 6.823

2.  rprimer: an R/bioconductor package for design of degenerate oligos for sequence variable viruses.

Authors:  Sofia Persson; Christina Larsson; Magnus Simonsson; Patrik Ellström
Journal:  BMC Bioinformatics       Date:  2022-06-18       Impact factor: 3.307

Review 3.  Effective high-throughput isolation of fully human antibodies targeting infectious pathogens.

Authors:  Lutz Gieselmann; Christoph Kreer; Meryem Seda Ercanoglu; Nathalie Lehnen; Matthias Zehner; Philipp Schommers; Julian Potthoff; Henning Gruell; Florian Klein
Journal:  Nat Protoc       Date:  2021-05-25       Impact factor: 13.491

4.  Designing sensitive viral diagnostics with machine learning.

Authors:  Hayden C Metsky; Nicole L Welch; Priya P Pillai; Nicholas J Haradhvala; Laurie Rumker; Sreekar Mantena; Yibin B Zhang; David K Yang; Cheri M Ackerman; Juliane Weller; Paul C Blainey; Cameron Myhrvold; Michael Mitzenmacher; Pardis C Sabeti
Journal:  Nat Biotechnol       Date:  2022-03-03       Impact factor: 68.164

5.  Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody.

Authors:  Philipp Schommers; Henning Gruell; Morgan E Abernathy; My-Kim Tran; Adam S Dingens; Harry B Gristick; Christopher O Barnes; Till Schoofs; Maike Schlotz; Kanika Vanshylla; Christoph Kreer; Daniela Weiland; Udo Holtick; Christof Scheid; Markus M Valter; Marit J van Gils; Rogier W Sanders; Jörg J Vehreschild; Oliver A Cornely; Clara Lehmann; Gerd Fätkenheuer; Michael S Seaman; Jesse D Bloom; Pamela J Bjorkman; Florian Klein
Journal:  Cell       Date:  2020-01-30       Impact factor: 41.582

6.  Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability.

Authors:  Deborah L Burnett; Katherine J L Jackson; David B Langley; Anupria Aggrawal; Alberto Ospina Stella; Matt D Johansen; Harikrishnan Balachandran; Helen Lenthall; Romain Rouet; Gregory Walker; Bernadette M Saunders; Mandeep Singh; Hui Li; Jake Y Henry; Jennifer Jackson; Alastair G Stewart; Franka Witthauer; Matthew A Spence; Nicole G Hansbro; Colin Jackson; Peter Schofield; Claire Milthorpe; Marianne Martinello; Sebastian R Schulz; Edith Roth; Anthony Kelleher; Sean Emery; Warwick J Britton; William D Rawlinson; Rudolfo Karl; Simon Schäfer; Thomas H Winkler; Robert Brink; Rowena A Bull; Philip M Hansbro; Hans-Martin Jäck; Stuart Turville; Daniel Christ; Christopher C Goodnow
Journal:  Immunity       Date:  2021-10-29       Impact factor: 43.474

7.  No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adults.

Authors:  Meryem Seda Ercanoglu; Lutz Gieselmann; Sabrina Dähling; Nareshkumar Poopalasingam; Susanne Detmer; Manuel Koch; Michael Korenkov; Sandro Halwe; Michael Klüver; Veronica Di Cristanziano; Hanna Janicki; Maike Schlotz; Johanna Worczinski; Birgit Gathof; Henning Gruell; Matthias Zehner; Stephan Becker; Kanika Vanshylla; Christoph Kreer; Florian Klein
Journal:  iScience       Date:  2022-02-19

8.  Prider: multiplexed primer design using linearly scaling approximation of set coverage.

Authors:  Niina Smolander; Timothy R Julian; Manu Tamminen
Journal:  BMC Bioinformatics       Date:  2022-05-12       Impact factor: 3.307

Review 9.  Exploiting B Cell Receptor Analyses to Inform on HIV-1 Vaccination Strategies.

Authors:  Christoph Kreer; Henning Gruell; Thierry Mora; Aleksandra M Walczak; Florian Klein
Journal:  Vaccines (Basel)       Date:  2020-01-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.